Connect with us

Published

on

Elon Musk said on Wednesday a wireless device developed by his brain chip company Neuralink is expected to begin human clinical trials in six months.

The company is developing brain chip interfaces that it says could enable disabled patients to move and communicate again. Based in the San Francisco Bay Area and Austin, Texas, Neuralink has in recent years been conducting tests on animals as it seeks US regulatory approval to begin clinical trials in people.

“We want to be extremely careful and certain that it will work well before putting a device into a human but we’ve submitted I think most of our paperwork to the FDA and probably in about six months we should be able to upload Neuralink in a human,” Musk said during a much-awaited public update on the device.

The event was originally planned for October 31 but Musk postponed it just days before without giving a reason.

Neuralink’s last public presentation, more than a year ago, involved a monkey with a brain chip that played a computer game by thinking alone.

Musk is known for lofty goals such as colonizing Mars and saving humanity. His ambitions for Neuralink, which he launched in 2016, are of the same grand scale. He wants to develop a chip that would allow the brain to control complex electronic devices and eventually allow people with paralysis to regain motor function and treat brain diseases such as Parkinson’s, dementia and Alzheimer’s. He also talks about melding the brain with artificial intelligence.

Neuralink, however, is running behind schedule. Musk said in a 2019 presentation he was aiming to receive regulatory approval by the end of 2020. He then said at a conference in late 2021 that he hoped to start human trials this year.

Neuralink has repeatedly missed internal deadlines to gain US Food and Drug Administration (FDA) approval to start human trials, current and former employees have said. Musk approached competitor Synchron earlier this year about a potential investment after he expressed frustration to Neuralink employees about their slow progress, Reuters reported in August.

Synchron crossed a major milestone in July by implanting its device in a patient in the United States for the first time. It received US regulatory clearance for human trials in 2021 and has completed studies in four people in Australia.

© Thomson Reuters 2022


Affiliate links may be automatically generated – see our ethics statement for details.

Continue Reading

Science

NASA’s Orion Control Room Prepares for Artemis II Lunar Mission

Published

on

By

NASA is preparing for Artemis II, the first crewed mission to the Moon since Apollo, with a new control hub at Johnson Space Center. The Orion Mission Evaluation Room (MER) will support flight controllers by monitoring Orion’s systems in real time during the 10-day mission. Staffed 24/7, the MER will compare telemetry with expected performance, troubleshoot issues, …

Continue Reading

Science

James Webb Space Telescope Spots Planet-Building Dust in the Butterfly Nebula

Published

on

By

The James Webb Space Telescope has unveiled stunning new details of the Butterfly Nebula, a planetary nebula 3,400 light-years away. Using its infrared vision, Webb detected crystalline silicates, large dust grains, and carbon-rich PAH molecules within the nebula’s dusty torus. These discoveries reveal how dying stars recycle minerals and organic compounds, spreadin…

Continue Reading

Science

China Unveils ‘Darwin Monkey’, World’s Largest Neuromorphic Supercomputer

Published

on

By

China has unveiled Darwin Monkey, the world’s largest neuromorphic supercomputer. With over 2 billion artificial neurons and 100 billion synapses, it mirrors a macaque brain’s complexity. Designed by Zhejiang University and Zhejiang Lab, the system could accelerate neuroscience simulations and advance artificial general intelligence while consuming only 2,000 watt…

Continue Reading

Trending